The largest database of trusted experimental protocols

Anti hla dr bv570

Manufactured by BD
Sourced in United States

Anti-HLA-DR-BV570 is a fluorochrome-conjugated antibody that binds to the HLA-DR antigen, which is a major histocompatibility complex (MHC) class II cell surface receptor. This antibody is commonly used in flow cytometry applications to identify and characterize cell populations expressing HLA-DR.

Automatically generated - may contain errors

2 protocols using anti hla dr bv570

1

Multiparametric Phenotyping of Peripheral Blood Mononuclear Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood mononuclear cells (PBMCs) were isolated using a Ficoll density gradient and stored with fetal bovine serum (FBS) and 10% dimethylsulfoxide (DMSO) in liquid nitrogen until the time of the assay. Cells were stained with a viability marker (LIVE/DEAD Fixable Violet Dead Cell Stain Kit 405nm, Life Technologies) and different fluorochrome-conjugated antibodies for 35 min at RT to assess the expression of surface marker expression. Anti-CD3, anti-CD19, anti-CD20, and anti-CD56 conjugated with V450 were used as a dump channel. Anti-CD14-BV650 and anti-CD16-PeCF594 (BD biosciences, USA) were used to classify different subsets of monocytes. Anti-TLR2-FITC, anti-HLA-DR-BV570, anti-CD40-APC (all BD Biosciences, USA), and anti-TLR4-BV786 (Biolegend, USA) were determined as activation markers. Anti-CX3CR1-PerCPCy5,5, anti-CCR2-BV605, anti-CD49d- BV711, anti-CD142-PE (all Biolegend, USA), anti-CCR5- APC-Cy7, and anti-CD11b-AF700 (all from BD Biosciences, USA) were used as maturation and homing markers. The cellular markers were analyzed by multiparametric flow cytometry using the Fortessa LSR II cytometer (BD Biosciences, Madrid, Spain). A minimum of 1x106 events were acquired per sample. Data were analyzed using Flowjo 9.3.2 software.
+ Open protocol
+ Expand
2

Evaluating ex vivo Tissue Viability

Check if the same lab product or an alternative is used in the 5 most similar protocols
To assay viability of cells in tissues ex vivo, tissue blocks were digested with collagenase IV at day 12. Cells from 3c-(10 μM) treated tissue blocks and untreated-control tissues were stained with anti-CD3QD655, anti-CD4QD605, anti-CD8QD800, anti-CD45RA-FITC, anti-CCR7-PECy7, anti-CXCR4-PE, and anti-CCR5-APC antibodies (stain 1) or stained with anti–CD3-QD655, anti–CD4-QD605, anti–CD8-QD800, anti-CD25-APC, anti-CD38-PE, anti-CD95-PE-Cy7, and anti-HLA-DR-BV570 antibodies (stain 2) (B&D Biosciences or Caltag laboratories, CA). Data were processed on a NovoCyte cytometer (AceaBiosciences, Inc). The depletion of each CD3+ lymphocytic cell subsets was assessed by using Trucount beads (Becton-Dickinson, NJ).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!